About: http://data.cimple.eu/news-article/a40518cb29bb845d499634afca4b48997ea3c42aab1ca41efae54db2

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/a40518cb29bb845d499634afca4b48997ea3c42aab1ca41efae54db2 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Brazil's health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an "adverse incident" involving a volunteer recipient, a blow for one of the most advanced vaccine candidates. The regulator, Anvisa, said in a statement it had "ruled to interrupt the clinical trial of the CoronaVac vaccine after a serious adverse incident" on October 29. It said it could not give details on what happened because of privacy regulations, but that such incidents included death, potentially fatal side effects, serious disability, hospitalization, birth defects and other "clinically significant events." The setback for CoronaVac, developed by Chinese pharmaceutical firm Sinovac Biotech, came on the same day US pharmaceutical giant Pfizer said its own vaccine candidate had shown 90 percent effectiveness, sending global markets soaring and raising hopes of an end to the pandemic. Both the Pfizer and Sinovac vaccines are in Phase III trials, the final stage of testing before regulatory approval. And both are being tested in Brazil, the country with the second-highest death toll in the pandemic, after the United States, with more than 162,000 people killed by the new coronavirus. CoronaVac has been caught up in a messy political battle in Brazil, where its most visible backer has been Sao Paulo Governor Joao Doria, a top opponent of far-right President Jair Bolsonaro. Bolsonaro has meanwhile labeled it the vaccine from "that other country," and pushed instead for a rival vaccine developed by Oxford University and pharmaceutical firm AstraZeneca. jhb/bgs
schema:headline	Brazil halts trials of Chinese Covid-19 vaccine
schema:mentions	Interrupt São Paulo USA Gymnastics Privacy Clinical trial Far-right politics Pharmaceutical industry Disability Sinovac Biotech National Sanitary Surveillance Agency President of Brazil University of Oxford AstraZeneca Jair Bolsonaro Pandemic Pfizer Brazil Vaccine United States China Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Hurricane Doria Governor of New Jersey
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-11-10 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	92 (xsd:integer)

Faceted Search & Find service v1.16.123 as of May 22 2025

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3241 as of May 22 2025, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 8 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2026 OpenLink Software